This site is intended for healthcare professionals only
LoginRegister
AstraZeneca to leave leading US drug lobby groupAstraZeneca to leave leading US drug lobby group
Zydus Lifesciences bags USFDA nod for hypotension injection Ephedrine SulfateZydus Lifesciences bags USFDA nod for hypotension injection Ephedrine Sulfate
Max Healthcare PAT jumps 86 percent to Rs 320 crore in Q4Max Healthcare PAT jumps 86 percent to Rs 320 crore in Q4
Eli Lilly Gets CDSCO Panel Nod to Import, Market antidiabetic drug TirzepatideEli Lilly Gets CDSCO Panel Nod to Import, Market antidiabetic drug Tirzepatide
CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin StudyAbbott Labs sued over PediaSure height claims
US Supreme Court rejects Teva challenge to USD 235 million GSK award in patent disputeUS Supreme Court rejects Teva challenge to USD 235 million GSK award in patent dispute
Dr Mansukh Mandaviya interacts with representatives of Japanese Pharma CompaniesDr Mansukh Mandaviya interacts with representatives of Japanese Pharma Companies
Biophore India Pharma gets CDSCO nod to manufacture, market Cannabidiol in IndiaBiophore India Pharma gets CDSCO nod to manufacture, market Cannabidiol in India
Pfizer discontinues development of danuglipron for chronic weight managementIndian unit of Pfizer reports 3 percent rise in Q4 profit
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuitGilead Sciences, Arcus Biosciences expand partnership to include research programs in inflammation
Prices of drugs going off patent to be reduced by 50 percentPrices of drugs going off patent to be reduced by 50 percent
Regulatory Approval not required for retrospective analysis of Inotuzumab ozogamicin: CDSCO panel Tells PfizerRegulatory Approval not required for retrospective analysis of Inotuzumab ozogamicin: CDSCO panel...
X